1. Pink Sheet

Pakistan Sets Deadline For Companies To Submit Pharmacovigilance Officer Notifications

 
• By Vibha Sharma

Pakistan’s medicines regulator is disappointed that so few drug companies have complied with a requirement notify to the National Pharmacovigilance Centre about their designated pharmacovigilance officers. 

Concept of health care, medicine, pharmacy, COVID-19, coronavirus. Assortment of pharmaceutical products, white and pink pills with a magnifying glass
Pakistan Implemented New Pharmacovigilance Rules In 2022 • Source: Alamy

The Drug Regulatory Authority of Pakistan has expressed concern over poor compliance by drug companies with the legal requirement to submit the details of their qualified person for pharmacovigilance (QPPV) or the local safety officer (LSO) to its National Pharmacovigilance Centre to ensure the safe use of drugs. 

DRAP is now giving companies until 15 September to provide details of their nominated QPPV/LSO to the NPC, as per Module 1 of

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Drug Safety

More from Pink Sheet

Austria To Fine Companies For Violating New Drug Stockpiling Rule

 
• By Neena Brizmohun

A new ordinance for addressing drug shortages in Austria requires drug companies distributing any of the hundreds of products listed in an accompanying annex to maintain adequate stock in the country to meet patient demand for four months.

EMA Explores Using AI Language Models To Refine Oncology Guidance

 
• By Vibha Sharma

The European Medicines Agency has for the first time explicitly stated it is considering the use of large language models as a tool to improve the readability of a scientific guideline.

Industry On Making England’s HTA Innovation Lab A Success

 
• By Eliza Slawther

England’s health technology assessment institute, NICE, must ensure that there is clarity for manufacturers on how its methods and processes might change following testing in its sandbox environment, the Association of the British Pharmaceutical Industry said.